ATP increases cAMP formation in bovine chromaffin cells, EC50 = 7.1 X 10(-6
) M. NPY, EC50 = 4.1 x 10(-8) M, increases the efficacy of ATP (1.5-2 fold)
. Inclusion of the selective Y1 receptor antagonist 1229U91 produced a decr
ease in NPY potency (EC50 = 2.7 x 10(-7) M). PTX pretreatment did not aboli
sh either the effect of ATP nor the enhancement by NPY. NPY could also enha
nce the ability of angiotensin and bradykinin to increase cAMP formation. T
he selective phospholipase C inhibitor, U73122, and the selective protein k
inase C inhibitors, bisindoiylmaleimide I and RO-31-8425, were effective in
hibitors of the enhancing effect of NPY. (C) 2001 Elsevier Science Inc. All
rights reserved.